Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity

v3.21.1
Condensed Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Balance at beginning of period at Dec. 31, 2019 $ 186,348 $ 7 $ 812,133 $ 80 $ (625,872)
Balance at beginning of period (in shares) at Dec. 31, 2019   68,882,459      
Stock-based compensation expense 1,998   1,998    
Net loss (13,088)       (13,088)
Net unrealized gain loss on marketable securities (210)     (210)  
Balance at end of period at Mar. 31, 2020 175,048 $ 7 814,131 (130) (638,960)
Balance at end of period (in shares) at Mar. 31, 2020   68,882,459      
Balance at beginning of period at Dec. 31, 2020 142,706 $ 7 819,549 8 (676,858)
Balance at beginning of period (in shares) at Dec. 31, 2020   68,946,092      
Stock-based compensation expense 2,505   2,505    
Net loss (17,551)       (17,551)
Net unrealized gain loss on marketable securities (14)     (14)  
Balance at end of period at Mar. 31, 2021 $ 127,646 $ 7 $ 822,054 $ (6) $ (694,409)
Balance at end of period (in shares) at Mar. 31, 2021   68,946,092